Home > Riviste > International Angiology > Fascicoli precedenti > International Angiology 2017 October;36(5) > International Angiology 2017 October;36(5):496-7

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

LETTERS TO THE EDITOR   Freefree

International Angiology 2017 October;36(5):496-7

DOI: 10.23736/S0392-9590.17.03819-6

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials

Witold TOMKOWSKI 1, Paweł KUCA 1 , Angelo A. BIGNAMINI 2, Giseppe M. ANDREOZZI 3

1 Polish Foundation against Thrombosis, National Tuberculosis and Lung Diseases Research Institute, Cardio-Pulmonary Intensive Care, Warsaw, Poland; 2 School of Specialization in Hospital Pharmacy, Department of Pharmaceutical Sciences, University of Milan, Milan, Italy; 3 Unit of Angiology, University Hospital, Padua, Italy


PDF


inizio pagina